. Author manuscript; available in PMC: 2018 Feb 23.

Published in final edited form as: Am J Prev Med. 2015 Aug 18;49(6 Suppl 4):S412–S425. doi: 10.1016/j.amepre.2015.03.005

Table 2.

Unadjusted adult vaccination coverage by race and ethnicity^a, National Health Interview Survey - 2012, United States

	Total unweighted N	Total weighted N	Non-Hispanic white	Non-Hispanic black	Hispanic	Non-Hispanic Asian	Other

			% (95% CI)	% (95% CI)	% (95% CI)	% (95% CI)	% (95% CI)
Influenza vaccination (past 12 months)^b
19–64	26,309	185,655,124	33.5 (32.4–34.5)	27.5 (25.8–29.3)^*	25.3 (23.5–27.1)^*	37.4 (34.5–40.3)^,^,^**	32.4 (27.5–37.7)^***
65+	7,234	40,926,304	68.8 (67.0–70.5)	53.0 (48.9–57.1)^*	57.5 (52.9–62.1)^*	65.2 (58.7–71.2)^**	56.5 (44.1–68.2)
Pneumococcal vaccination (ever received)
19–64 HR^c	9,333	63,041,071	21.4 (20.1–22.9)	19.7 (17.4–22.2)	13.8 (11.5–16.4)^,^*	13.2 (9.5–18.1)^,^*	20.2 (15.2–26.2)^*,^**
65+	7,076	40,052,113	64.0 (62.3–65.7)	46.1 (41.7–50.6)^*	43.4 (39.0–48.0)^*	41.3 (35.4–47.5)^*	44.7 (32.6–57.5)^*
Tetanus vaccination (past 10 yrs)
19–64	25,452	179,536,112	68.9 (67.9–69.9)	54.9 (52.8–57.0)^*	53.6 (51.6–55.6)^*	52.8 (49.6–56.0)^*	71.5 (66.7–75.8)^,^,^***
65+	6,905	39,054,443	57.7 (55.9–59.5)	44.6 (40.8–48.4)^*	44.8 (40.1–49.6)^*	45.8 (39.5–52.2)^*	50.2 (36.8–63.6)
Shingles vaccination (ever received)
60+	9,924	58,333,459	22.8 (21.5–24.0)	8.8 (6.9–11.2)^*	8.7 (6.6–11.4)^*	16.9 (13.2–21.5)^,^,^**	19.7 (11.5–31.6)^,^*
Human papillomavirus vaccination (≥ 1 dose)
19–26 Female	2,300	16,721,170	42.2 (38.5–46.0)	29.1 (23.4–35.7)^*	18.7 (14.9–23.1)^,^*	15.6 (9.5–24.5)^,^*	41.2 (28.7–55.0)^*,^**

Note: Boldface indicates significance.

Abbreviations: CI=Confidence interval.

Persons of Hispanic or Latino origin may be of any race or combination of races. “Others” included American Indian/Alaska Native, and multiple race.

Influenza vaccination coverage estimates represent the proportion of respondents who answered that they had received an influenza vaccination in the past 12 months based on NHIS 2012 data. These estimates may differ from the Kaplan Meier influenza vaccination coverage estimates based on coverage for an influenza season (e.g. NHIS interviews conducted from September 2012 through June 2013 and vaccinations received from July 2012 through May 2013) published on FluVaxView (http://www.cdc.gov/flu/fluvaxview/nhis-flu-vax.htm).

Adults were considered at high risk for pneumococcal disease if they had ever been told by a doctor or other health professional that they had diabetes, emphysema, chronic obstructive pulmonary disease, coronary heart disease, angina, heart attack, or other heart condition; had a diagnosis of cancer during the previous 12 months (excluding nonmelanoma skin cancer); had ever been told by a doctor or other health professional that they had lymphoma, leukemia, or blood cancer; or they had been told by a doctor or other health professional that they had chronic bronchitis or weak or failing kidneys during the preceding 12 months or had an asthma episode or attack during the preceding 12 months; or they were current smokers.

p < 0.05 by t-test (comparing against non-Hispanic white).

^**

p < 0.05 by t-test (comparing against non-Hispanic black).

^***

p < 0.05 by t-test (comparing against Hispanic).

^****

p < 0.05 by t-test (comparing against non-Hispanic Asian).